|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients 显示文摘 | Schmidt LE Olsen AK Stentoft K | 2001 | Clin Pharmacol Ther2001，70，5： | 2 |
| 2 | Review of Cefditoren an advanced-- generation broad--spectrum oral cephalosporin显示文摘 | Gnay DR | 2001 | clin ther2001，23，12： | 2 |
| 3 | Simultaneous modeling of pharmacokinetic and pharmacodynamics: application to D-tubocurarine 显示文摘 | Sheiner LB Stanski DR Vozeh S | 1979 | Clin Pharmacol Ther1979，25，3： | 2 |
| 4 | Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite 显示文摘 | Sum CR Yacobi A Kartzinel R | 1983 | Clin Pharmacol Ther1983，34，： | 2 |
| 5 | Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity 显示文摘 | Chiou WL Jeong HY Wu TC | 2001 | Clin Pharmacol Ther2001，70，： | 2 |
| 6 | Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers 显示文摘 | Yasuda S Ohnishi A Ogawa T | 1994 | Int J Clin Pharmacol Ther1994，32，9： | 2 |
| 7 | CYP3A activity in European American and Japanese men using midazolam as an in vivo probe显示文摘 | Tateishi T Watanabe M Nakura H | 2001 | Clin Pharmacol Ther2001，69，： | 2 |
| 8 | Zoledronic acid: a new parenteral bisphosphonate 显示文摘 | Li EC Davis LE | 2003 | Clin Ther2003，25，11： | 2 |
| 9 | The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin显示文摘 | Gorski JC Jones DR Haehner-Daniels BD | 1998 | Clin Pharmacol Ther1998，64，： | 2 |
| 10 | Comparison of in vivo and in vitro efficacy of ceftizoxime 显示文摘 | Delaney M L Cisneros R L | 1990 | Clin Ther1990，12，： | 2 |
| 11 | Sorption studies of dipotassium elorazepate salt ( Tranxene ) and midazolam hydrochloride ( Hypnovel ) in polyvinyl chloride and glass infusion containers显示文摘 | Bianehi C Airaudo CB | 1992 | J Clin Pharm Ther1992，17，： | 1 |
| 12 | Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection 显示文摘 | Van Rossum TG Vuho AG Hop WC | 1999 | Clin Ther1999，21，12： | 1 |
| 13 | The pharmacogenetics research network: from SNP discovery to clinical drug response显示文摘 | Giacomini KM Brett CM Altman RB etal | 2007 | Clin Pharmacol Ther2007，81，3： | 1 |
| 14 | The p rog-nostic significance of membrane transport2associated multidrug resistance (MDR) proteins in leukenia 显示文摘 | Van der Heuvel-EibrinkM M Sonneveld P Pieters R | 2000 | Int J Clin Pharmacol Ther2000，38，3： | 1 |
| 15 | Efficacyandtolerabilityof eseitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients显示文摘 | YEVTUSHENKO VY BELOUS AI YEVTUSHENKO YG et ol | 2007 | Clin Ther2007，29，11： | 1 |
| 16 | Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension 显示文摘 | SASAKI J KAJIYAMA G KUSUKAWA R | 1995 | Int J Clin Pharmacol Ther1995，33，6： | 1 |
| 17 | Cypzc9,but not cypzc19,polymorphisms affect the pharmaco rineties and pharmacodynamics of glyburide in chinese subjects显示文摘 | Yin OQ Tomlinson B Chow MS | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 18 | Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study 显示文摘 | Pedersen RS Damkier P Brosen K | 2005 | Clin Pharmacol Ther2005，77，： | 1 |
| 19 | Inhibition of human cytochrome P450 isoforms and NADPH CYP reductase in vitro by 15 herbal medicines, including Epimedii Herba显示文摘 | Liu KH Kim MJ Jeon BH | 2006 | J Clin Pharm Thers2006，31，1： | 1 |
| 20 | Efficacy,tolerability,and effects on quality of life of losartan,alone or with hydrochlorothiazide,in patients with essential hypertension显示文摘 | Bar E Elkins M | 1996 | Clin Ther1996，18，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员